BAYER AG
BAYRY
12.26
-0.16
-1.29%
BAYER AG
US · BAYRY
#444 by market cap
Listed 1970
12.26
-0.16
-1.29%
Live - 5344 symbols - heartbeat 524s ago
· 2026-10-08 19:40
- Market cap
- 49.67B
- P/Bi
- 1.45
- EPSi
- -0.51
- Div yieldi
- 0.26%
- 52W posi
- 62%
Reader sentiment
Are you bullish or bearish on BAYRY?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Bayer's (BAYRY.US) application for the new indication of Finerenone tablets has been approved for listing in China.Zhitong Finance · 2025/1/24
-
Bayer (BAYRY.US) has received approval for its first-in-class new drug.Zhitong Finance · 2025/7/14
-
Bayer (BAYRY.US) announced that Sevabertinib has received FDA priority review for the treatment of HER2 mutated NSCLC.Zhitong Finance · 2025/5/29
-
Barclays Initiates BAYER AG(BAYRY.US) With Buy RatingMarket Newswire · 2026/1/7
-
Bayer (BAYRY.US) subsidiary's gene therapy for Parkinson's disease has been granted advanced therapy designation by the FDA.Zhitong Finance · 2025/2/20
-
Rating change
Berenberg Bank Maintains BAYER AG(BAYRY.US) With Hold Rating, Cuts Target Price to $5.8Market Newswire · 2024/11/20
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 19:40:37 · For reference only, not investment advice and not tailored to your situation.